Academic literature on the topic 'Bilirubin-induced neurologic dysfunction'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Bilirubin-induced neurologic dysfunction.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Bilirubin-induced neurologic dysfunction"

1

Bhutani, Vinod K., and Ronald Wong. "Bilirubin-induced neurologic dysfunction (BIND)." Seminars in Fetal and Neonatal Medicine 20, no. 1 (2015): 1. http://dx.doi.org/10.1016/j.siny.2014.12.010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Johnson, Lois, and Vinod K. Bhutani. "The Clinical Syndrome of Bilirubin-Induced Neurologic Dysfunction." Seminars in Perinatology 35, no. 3 (2011): 101–13. http://dx.doi.org/10.1053/j.semperi.2011.02.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bhutani, Vinod K., and Lois Johnson-Hamerman. "The clinical syndrome of bilirubin-induced neurologic dysfunction." Seminars in Fetal and Neonatal Medicine 20, no. 1 (2015): 6–13. http://dx.doi.org/10.1016/j.siny.2014.12.008.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Morioka, Ichiro, Sota Iwatani, Tsubasa Koda, Kazumoto Iijima, and Hajime Nakamura. "Disorders of bilirubin binding to albumin and bilirubin-induced neurologic dysfunction." Seminars in Fetal and Neonatal Medicine 20, no. 1 (2015): 31–36. http://dx.doi.org/10.1016/j.siny.2014.11.001.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wusthoff, Courtney J., and Irene M. Loe. "Impact of bilirubin-induced neurologic dysfunction on neurodevelopmental outcomes." Seminars in Fetal and Neonatal Medicine 20, no. 1 (2015): 52–57. http://dx.doi.org/10.1016/j.siny.2014.12.003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Wong, Ronald J., and David K. Stevenson. "Neonatal hemolysis and risk of bilirubin-induced neurologic dysfunction." Seminars in Fetal and Neonatal Medicine 20, no. 1 (2015): 26–30. http://dx.doi.org/10.1016/j.siny.2014.12.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lakatos, Lajos, and György Balla. "Dysregulation of brain metal homeostasis in bilirubin-induced neurologic dysfunction." Journal of Trace Elements in Medicine and Biology 36 (July 2016): 90. http://dx.doi.org/10.1016/j.jtemb.2016.03.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Alaba, Emmanuel Oluwaseun, Iyabode Olabisi Florence Dedeke, and Dominic Donatus Agbo. "Utilizing the Bilirubin-Albumin Ratio as a Predictive Marker for Bilirubin-Induced Neurologic Dysfunction: A Comparative Analysis in Two Referral Hospitals in Abeokuta." Journal of Advances in Medicine and Medical Research 36, no. 2 (2024): 125–34. http://dx.doi.org/10.9734/jammr/2024/v36i25373.

Full text
Abstract:
Aim: We aim to assess the predictive value of Bilirubin Albumin Ratio (BAR) for evaluating bilirubin-induced neurologic dysfunction (BIND). Bilirubin-induced neurologic dysfunction is a major cause of morbidity in neonates with highest burden in Sub-Saharan Africa and other resource-limited settings. Bilirubin Albumin Ratio (BAR) has been purported to correlate better with BIND than total serum bilirubin (TSB) which is the conventional tool used in evaluating babies with severe hyperbilirubinemia. There is however paucity of studies utilizing BAR in evaluating BIND.
 Study Design: The stu
APA, Harvard, Vancouver, ISO, and other styles
9

Bhutani, Vinod K., and David K. Stevenson. "The Need for Technologies to Prevent Bilirubin-Induced Neurologic Dysfunction Syndrome." Seminars in Perinatology 35, no. 3 (2011): 97–100. http://dx.doi.org/10.1053/j.semperi.2011.02.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Shapiro, Steven M., and Gerald R. Popelka. "Auditory Impairment in Infants at Risk for Bilirubin-Induced Neurologic Dysfunction." Seminars in Perinatology 35, no. 3 (2011): 162–70. http://dx.doi.org/10.1053/j.semperi.2011.02.011.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Bilirubin-induced neurologic dysfunction"

1

van Imhoff, Deirdre E., Frans J. C. Cuperus, Peter H. Dijk, Claudio Tiribelli, and Christian V. Hulzebos. "Kernicterus, Bilirubin Induced Neurological Dysfunction and New Treatments for Unconjugated Hyperbilirubinemia." In Neonatology. Springer Milan, 2012. http://dx.doi.org/10.1007/978-88-470-1405-3_83.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Hulzebos, C. V., C. Tiribelli, F. J. C. Cuperus, and P. H. Dijk. "Kernicterus, Bilirubin-Induced Neurological Dysfunction, and New Treatments for Unconjugated Hyperbilirubinemia in Neonates." In Neonatology. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-18159-2_222-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hulzebos, Christian V., Claudio Tiribelli, Frans J. C. Cuperus, and Petr H. Dijk. "Kernicterus, Bilirubin-Induced Neurological Dysfunction, and New Treatments for Unconjugated Hyperbilirubinemia in Neonates." In Neonatology. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-29489-6_222.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

"Jaundice." In ACoRN: Acute Care of at-Risk Newborns, edited by Jill E. Boulton, Kevin Coughlin, Debra O'Flaherty, and Alfonso Solimano. Oxford University Press, 2021. http://dx.doi.org/10.1093/med/9780197525227.003.0008.

Full text
Abstract:
The jaundice chapter illustrates how to stabilize newborns with hyperbilirubinemia—a common condition—and avoid their developing severe hyperbilirubinemia. Prevention is accomplished by transcutaneous bilirubin testing, total serum bilirubintests, and the use of nomograms to evaluate risk for hyperbilirubinemia and direct appropriate care. Specific risk factors for jaundice and hyperbilirubinemia, treatment thresholds for phototherapy treatment or exchange transfusion, and a bilirubin-induced neurological dysfunction scoring tool for assessing severity in acute bilirubin encephalopathy cases a
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!